Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T, Teo SM, Yeo HL, Shwe M, Gan YX, Cheung YT, Foo KM, Cham MT, Lee JA, Tan YP, Fan G, Yong WS, Preetha M, Loh WJ, Koo SL, Jain A, Lee GE, Wong M, Dent R, Yap YS, Ng R, Khor CC, Ho HK, Chan A.
Ng T, et al. Among authors: shwe m.
Neuro Oncol. 2016 Feb;18(2):244-51. doi: 10.1093/neuonc/nov162. Epub 2015 Aug 19.
Neuro Oncol. 2016.
PMID: 26289590
Free PMC article.